Strata Critical Medical reported revenue of $72.51M and net income of -$10.52M for the quarter ended Jun 2026, up 60.7% year over year. This income statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||
| Revenue | 42.54M | 26.63M | 62.26M | 45.27M | 60.99M | 71.44M | 47.48M | 51.51M | 67.94M | 36.06M | 36.39M | 35.95M | 45.11M | 49.30M | 66.79M | 67.38M | 72.51M | ||||||||||||
| Cost of RevenueCost of Rev | 33.63M | 23.71M | 54.23M | 38.11M | 50.62M | 55.86M | 38.47M | 41.38M | 51.59M | 28.55M | 31.37M | 28.89M | 36.10M | 37.68M | 55.12M | 53.27M | 57.29M | ||||||||||||
| Gross Profit | 8.91M | 2.92M | 8.03M | 7.16M | 10.37M | 15.58M | 9.01M | 10.14M | 16.35M | 7.51M | 5.01M | 7.05M | 9.01M | 11.61M | 11.67M | 14.12M | 15.21M | ||||||||||||
| Operating items | |||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.41M | 0.36M | 1.49M | 6.63M | |||||||||||||||||||||||||
| Research & DevelopmentR&D | 2.43M | 1.80M | 3.44M | 2.61M | 2.73M | 2.69M | 2.41M | 2.13M | 2.40M | 0.42M | 6.92M | 1.44M | 1.63M | 0.48M | |||||||||||||||
| Selling, General & AdministrativeSG&A | 26.75M | 13.98M | 26.12M | 16.26M | 18.41M | 19.27M | 41.24M | 17.21M | 25.14M | 13.87M | 11.72M | 12.33M | 13.29M | 16.30M | 17.92M | 15.61M | 14.00M | ||||||||||||
| Other Operating ExpensesOther Opex | 35.08M | 24.54M | 56.13M | 39.23M | 52.06M | 56.94M | 39.46M | 42.05M | 52.56M | 28.87M | -93.57M | -1.03M | -1.28M | 38.14M | -100.74M | 1.49M | 6.63M | ||||||||||||
| Operating ExpensesOpex | 64.27M | 40.32M | 85.69M | 58.10M | 73.20M | 78.89M | 83.11M | 61.38M | 80.09M | 43.15M | -74.94M | 12.74M | 13.65M | 54.92M | -82.82M | 17.09M | 20.62M | ||||||||||||
| Operating IncomeOp. Inc | -21.73M | -13.69M | -23.42M | -12.83M | -12.21M | -7.45M | -35.63M | -9.87M | -12.15M | -7.09M | -5.90M | -5.68M | -4.64M | -5.62M | -6.41M | -2.97M | -5.41M | ||||||||||||
| EBIT | -21.73M | -13.69M | -23.42M | -12.83M | -12.21M | -7.45M | -35.63M | -9.87M | -12.15M | -7.09M | -5.90M | -5.68M | -4.64M | -5.62M | -6.41M | -2.97M | -5.41M | ||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | -0.14M | ||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 2.08M | 2.15M | 2.26M | 2.07M | 1.79M | 1.76M | 1.59M | 1.32M | 1.16M | 1.13M | 0.64M | 0.47M | 0.33M | ||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | |||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -19.61M | 2.68M | 20.82M | 2.44M | -0.40M | 7.87M | 0.67M | 5.55M | 0.88M | 1.47M | -1.53M | 4.07M | 1.23M | -4.04M | 1.02M | 5.38M | -5.11M | ||||||||||||
| Net income details | |||||||||||||||||||||||||||||
| EBT | -41.33M | -11.01M | 8.41M | -10.39M | -12.61M | 0.42M | -34.96M | -4.32M | -11.27M | -5.63M | -7.43M | -1.61M | -3.41M | -9.66M | -5.39M | 2.40M | -10.52M | ||||||||||||
| Tax ProvisionsTaxes | -3.64M | -0.20M | -0.38M | 0.13M | -1.02M | -0.08M | 0.05M | ||||||||||||||||||||||
| Profit After TaxPAT | -40.05M | -11.01M | 8.41M | -27.26M | -10.19M | -12.23M | 0.29M | -33.94M | -4.23M | -11.33M | -5.63M | -9.79M | -3.49M | -3.74M | 57.42M | -8.83M | 2.40M | -10.52M | |||||||||||
| Income from Continuing OperationsIncome (Continuing) | -37.69M | -11.01M | 8.41M | -10.19M | -12.23M | 0.29M | -33.94M | -4.23M | -11.33M | -5.63M | -7.43M | -1.61M | -3.41M | -9.66M | -5.39M | 2.40M | -10.52M | ||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | 3.67M | -2.36M | -1.88M | -0.33M | 67.07M | -3.44M | -0.25M | ||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -37.69M | -11.01M | 8.41M | -10.19M | -12.23M | 0.29M | -33.94M | -4.23M | -11.33M | -1.95M | -9.79M | -3.49M | -3.74M | 57.42M | -8.83M | 2.15M | -10.52M | ||||||||||||
| Income towards Parent CompanyParent Net Inc | -37.69M | -11.01M | 8.41M | -10.19M | -12.23M | 0.29M | -33.94M | -4.23M | -11.33M | -1.95M | -9.79M | -3.49M | -3.74M | 57.42M | -8.83M | 2.15M | -10.52M | ||||||||||||
| Net Income towards Common StockholdersNet Income | -37.69M | -11.01M | 8.41M | -10.19M | -12.23M | 0.29M | -33.94M | -4.23M | -11.33M | -1.95M | -9.79M | -3.49M | -3.74M | 57.42M | -8.83M | 2.15M | -10.52M | ||||||||||||
| Additional items | |||||||||||||||||||||||||||||
| EPS (Basic) | -0.55 | -0.16 | 0.12 | -0.14 | -0.17 | 0.00 | -0.46 | -0.06 | -0.15 | -0.03 | -0.13 | -0.04 | -0.05 | 0.70 | -0.11 | 0.03 | -0.12 | ||||||||||||
| EPS (Diluted) | -0.55 | -0.16 | 0.11 | -0.14 | -0.17 | 0.00 | -0.46 | -0.06 | -0.15 | -0.03 | -0.13 | -0.04 | -0.05 | 0.70 | -0.11 | 0.02 | -0.12 | ||||||||||||
| Shares Outstanding | 69.01M | 69.76M | 70.77M | 71.05M | 71.47M | 71.24M | 71.99M | 73.17M | 74.14M | 73.52M | 75.80M | 77.60M | 78.04M | 77.50M | 79.89M | 81.30M | 82.45M | 82.09M | 85.32M | 86.21M | |||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 69.01M | 77.68M | 70.77M | 78.50M | 71.47M | 71.24M | 71.99M | 73.17M | 81.01M | 73.52M | 75.80M | 77.60M | 78.04M | 77.50M | 79.89M | 81.30M | 82.45M | 82.09M | 90.17M | 86.21M | |||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 70.55M | 70.67M | 70.87M | 71.43M | 71.65M | 72.04M | 73.17M | 74.11M | 74.63M | 75.43M | 77.35M | 77.93M | 78.31M | 79.69M | 81.02M | 81.70M | 86.37M | 86.99M | 86.53M | 88.47M | |||||||||
| EBITDA | -21.73M | -13.69M | -23.42M | -12.83M | -12.21M | -7.45M | -35.63M | -9.87M | -12.15M | -7.09M | -5.90M | -5.68M | -4.64M | -5.62M | -6.41M | -2.97M | -5.41M | ||||||||||||
| Tax Rate | 8.81% | 1.89% | 2.98% | 30.86% | 2.93% | 1.95% | -0.46% |